{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib3ut2ku4cpiakopww3y6nnafkfi2m7363ycxjcjrc6aolhsyqeee",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mlm7h2onir62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreica5fmq4avn6b5l4g6dxfa4pytzjmbjfm7mtcffnrr3ffzztfxteu"
    },
    "mimeType": "image/jpeg",
    "size": 78230
  },
  "path": "/pharmalot/2026/05/11/colombia-dolutegravir-court-case-patent-cost/?utm_campaign=rss",
  "publishedAt": "2026-05-11T19:57:25.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "HIV/AIDS",
    "patents",
    "Pharmaceuticals",
    "Policy",
    "public health",
    "STAT+"
  ],
  "textContent": "A South American court upheld the steps taken by the Colombian government when it issued a compulsory license two years ago for an HIV medicine.",
  "title": "STAT+: Colombia wins a key court ruling over a compulsory license issued for an HIV medicine",
  "updatedAt": "2026-05-11T20:50:43.000Z"
}